Comparing two types of engineered enzymes to treat psoriasis
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
This study is looking at new ways to deliver special enzymes that can help calm down the immune system and reduce inflammation in people with psoriasis, a skin condition that can be really bothersome.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11009926 on NIH RePORTER |
What this research studies
This research investigates innovative ways to administer engineered enzymes that can help redirect immune cells from causing chronic inflammation to restoring balance in the body. The study focuses on two forms of these enzymes: one that is anchored to tissues and another that circulates in the bloodstream. By examining how these different administration methods affect immune responses, the research aims to identify the most effective approach for treating psoriasis, a chronic autoimmune condition that can severely impact skin health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with psoriasis or other related autoimmune conditions.
Not a fit: Patients with psoriasis who are not responsive to immunotherapy or those with other unrelated skin conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new therapeutic options for patients suffering from psoriasis, potentially improving their quality of life.
How similar studies have performed: Previous research has shown promise in using engineered enzymes for immune modulation, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Keselowsky, Benjamin George — University of Florida
- Study coordinator: Keselowsky, Benjamin George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.